The continued stigma surrounding mental health and the increase in depression diagnosis in the U.S. is cause for multidisciplinary collaboration and research to explore additional treatment pathways for those experiencing mental illness. This panel brings together the expert voices of neuroscience, psychiatry, advocacy and industry to discuss the collaborative pursuit of innovative treatment approaches to depression and what future treatments might look like for people who do not respond to “traditional” therapies.